Skip to main content

Table 2 Characteristics of included studies (other kinds of interventions)

From: Optimizing acupuncture treatment for dry eye syndrome: a systematic review

First author Year Site Sample sizea Age Gender (M/F) Regime (intervention/control group) Regime (frequency & duration) Outcomes
Shin [26] 2010 Korea 42 (21/21) 41.6 11/31 Intervention: manual acupuncture GV23, BL2, BL14, TE23, Ex-HN5, ST-1, GB20, SP3, LU9, LU10, HT8
Control: non-acupoints around same site
Needles were retained for 20 min, 3 times a week for a total of 9 times. It takes 3 weeks to complete the treatment. BUT, SIT, VAS, OSDI
Liu [27] 2012 China 39 (20/19) 32 21/19 Intervention: electro-acupuncture with BL1, Ex-HN5, BL2, TE23, GB1, GB20, KI3, SP6, LR3
Control: Artificial tears
Everyday treatment group undergoes electroacupuncture for 30 min. For a total of 20 sessions. SIT, BUT
Guo [28] 2013 China 47 (23/24) 52 7/40 Intervention: electro-acupuncture with shang-jingming (Ex), xia-jingming (Ex), GB1, BL2, GB20, LI4, SP6, KI3, LR3
Control: manual acupuncture with the same acupoints
Needles were retained for 20 min, 3 times a week for a total of 12 times. It takes 4 weeks to complete the treatment. BUT, SIT, VAS
Gao [29] 2016 China 88 (44/44) 41.8 33/55 A: pyonex combined with acupuncture, SP6, ST36, PC6, LR3 are the main points, and pattern identification was done (BL13, LI4 OR BL20, ST40 OR BL18, BL23)
B: manual acupuncture with GV20, ST1, BL2, GB20, Ex-HN5, TE23
A: pyonex was embedded for 3 days. The follwing day, it was embedded again. This process was repeated four times and followed by two days free from embedment. After that, another four courses of embedment were conducted.
B: needles were retained for 30 min every day for 12 days. Two days rest were followed by another 12 days of treatment.
SIT BUT, total score
Wu [30] 2016 China 40 (20/20) 44.2 10/30 Intervention: BL2, ST2, Ex-HN5
Control: artificial tears
Treatment group undergoes embedding therapy (retained for 24 h) on alternate days for 7 sessions. BUT, SIT, OSDI
  1. M/F male/female, ST Schirmer’s test, BUT break-up time, OSDI ocular surface disease index, a questionnaire
  2. aTotal sample size (number in intervention group/number in control group)